Clinical studies also reported reduced inflammation and amelioration of body weight loss by IL‐6 signalling pathway inhibition,30, 31 indicating that targeting IL‐6 signalling may be a promising adjunct strategy for cancer treatment. Here, IL6 is linked to cancer.